Neurofibromatosis Archive

July 12, 2018

Study seeks to devise tools to evaluate changes in bone quality

Sometimes it makes sense to put the cart in front of the horse.

April 12, 2018

VICC to host symposium on neurofibromatosis April 21

Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave.

By VUMC News and Communications

November 9, 2017

Vanderbilt joins national neurofibromatosis network

The Vanderbilt-Ingram Cancer Center Neurofibromatosis (NF) Clinic has joined the Children’s Tumor Foundation NF Clinic Network.

By Tom Wilemon

May 6, 2015

Neurofibromin fine-tunes bone growth

The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered.

By Leigh MacMillan

September 11, 2014

Bone healing therapy for NF1 fractures

A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1.

By VUMC News and Communications

August 7, 2014

Novel treatment strengthens bones in genetic disease

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.

By Leigh MacMillan

July 31, 2013 Factor’s role in long bone development
Insight into how the protein neurofibromin participates in the signaling pathway that produces the body’s long bones has implications for fracture healing in some patients.
By Leigh MacMillan
November 18, 2011 Skeletal defects in genetic disorder
A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis.
By Leigh MacMillan